glp-1 / weight‑loss drugs

GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial — Phot

4 Hidden Dilemmas In Obesity Treatment That Drain Budgets

GLP-1 drugs can reduce obesity treatment costs when their dual impact on weight and alcohol use is leveraged, but hidden dilemmas can erode savings. A small, 12-patient trial found a 51% reduction in heavy-drinking days while BMI fell 7.5% after six weeks of semaglutide, showing a concrete economic win